320 related articles for article (PubMed ID: 21466276)
1. Sequential therapy in the treatment of osteoporosis.
Boonen S; Milisen K; Gielen E; Vanderschueren D
Curr Med Res Opin; 2011 Jun; 27(6):1149-55. PubMed ID: 21466276
[TBL] [Abstract][Full Text] [Related]
2. Combination of anabolic and antiresorptive agents for the treatment of osteoporosis.
Garcés C; García LE
Maturitas; 2006 Apr; 54(1):47-54. PubMed ID: 16257150
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of osteoporosis with parathyroid hormone].
Syversen U; Halse JI
Tidsskr Nor Laegeforen; 2008 Jan; 128(1):39-41. PubMed ID: 18183056
[TBL] [Abstract][Full Text] [Related]
4. [New development in bisphosphonate treatment. Clinical significance of combinatorial therapies with bisphosphonates and parathyroid hormone for osteoporosis].
Takeuchi Y
Clin Calcium; 2009 Jan; 19(1):85-90. PubMed ID: 19122268
[TBL] [Abstract][Full Text] [Related]
5. Prevention and treatment of osteoporotic fractures.
Gardner MJ; Demetrakopoulos D; Shindle MK; Griffith MH; Lane JM
Minerva Med; 2005 Oct; 96(5):343-52. PubMed ID: 16227949
[TBL] [Abstract][Full Text] [Related]
6. [Anabolic treatment for osteoporosis: PTH treatment].
Kaji H; Sugimoto T
Clin Calcium; 2006 Sep; 16(9):1480-85. PubMed ID: 16951472
[TBL] [Abstract][Full Text] [Related]
7. Parathyroid hormone treatment for osteoporosis.
Cosman F
Curr Opin Endocrinol Diabetes Obes; 2008 Dec; 15(6):495-501. PubMed ID: 18971677
[TBL] [Abstract][Full Text] [Related]
8. [Treatment with recombinant parathyroid hormone of advanced osteoporosis--series of cases].
Skiba K; Adamczak M; Wiecek A
Przegl Lek; 2011; 68(7):391-5. PubMed ID: 22010479
[TBL] [Abstract][Full Text] [Related]
9. Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: an 18-month, multicenter, open-label, prospective study.
Adachi JD; Hanley DA; Lorraine JK; Yu M
Clin Ther; 2007 Sep; 29(9):2055-67. PubMed ID: 18035204
[TBL] [Abstract][Full Text] [Related]
10. [Effect and role of teriparatide in the treatment of osteoporosis].
Nakamura T
Clin Calcium; 2012 Mar; 22(3):309-14. PubMed ID: 22370296
[TBL] [Abstract][Full Text] [Related]
11. Anabolic therapies for osteoporosis.
Uihlein AV; Leder BZ
Endocrinol Metab Clin North Am; 2012 Sep; 41(3):507-25. PubMed ID: 22877427
[TBL] [Abstract][Full Text] [Related]
12. Bisphosphonate therapy for osteoporosis: combining optimal fracture risk reduction with patient preference.
Beard MK
Curr Med Res Opin; 2012 Jan; 28(1):141-7. PubMed ID: 22103779
[TBL] [Abstract][Full Text] [Related]
13. The prevention and treatment of osteoporosis: a review.
Cosman F
MedGenMed; 2005 May; 7(2):73. PubMed ID: 16369451
[TBL] [Abstract][Full Text] [Related]
14. Combination antiresorptive and osteoanabolic therapy for osteoporosis: we are not there yet.
Cusano NE; Bilezikian JP
Curr Med Res Opin; 2011 Sep; 27(9):1705-7. PubMed ID: 21740288
[TBL] [Abstract][Full Text] [Related]
15. Trends and determinants of antiresorptive drug use for osteoporosis among elderly women.
Perreault S; Dragomir A; Desgagné A; Blais L; Rossignol M; Blouin J; Moride Y; Ste-Marie LG; Fernandès JC
Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):685-95. PubMed ID: 15645517
[TBL] [Abstract][Full Text] [Related]
16. Combination anabolic and antiresorptive therapy for osteoporosis.
Cusano NE; Bilezikian JP
Endocrinol Metab Clin North Am; 2012 Sep; 41(3):643-54. PubMed ID: 22877434
[TBL] [Abstract][Full Text] [Related]
17. [Parathyroid and bone. Evidence and perspective of parathyroid therapy for patients with osteoporosis].
Wada S; Fukawa T; Kamiya S
Clin Calcium; 2007 Dec; 17(12):1888-94. PubMed ID: 18057665
[TBL] [Abstract][Full Text] [Related]
18. Combination/sequential therapies for anabolic and antiresorptive skeletal agents for osteoporosis.
Bilezikian JP; Rubin MR
Curr Osteoporos Rep; 2006 Mar; 4(1):5-13. PubMed ID: 16527002
[TBL] [Abstract][Full Text] [Related]
19. [Parathyroid and bone. Role of parathyroid hormone in the treatment of osteoporosis].
Nakamura T
Clin Calcium; 2007 Dec; 17(12):1823-9. PubMed ID: 18057656
[TBL] [Abstract][Full Text] [Related]
20. Effects of parathyroid hormone alone or in combination with antiresorptive therapy on bone mineral density and fracture risk--a meta-analysis.
Vestergaard P; Jorgensen NR; Mosekilde L; Schwarz P
Osteoporos Int; 2007 Jan; 18(1):45-57. PubMed ID: 16951908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
